Fairfax Media network navigation

  • Home
  • Shares
  • Share details

BIONICHE LIFE SCIENCES INC. (BNC)


Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

Sign Up Today » it's FREE! Already a member? Login now!


General Information
Company Name: Bioniche Life Sciences Inc
Stock Code: BNC
Website: www.bioniche.com
GICS Sub-Industry: Pharmaceuticals
Market Cap ($M): 1
Equiv. Shares (M): 2

Current Price Data+
Current Price Open High Low Last Close Volume Price Movement
$ 0.300 $ 0.000 $ 0.000 $ 0.000 $ 0.300 0 0%

Company Overview

Business Description:
Bioniche Life Sciences Inc. (BNC) is a research-based, technology-driven Canadian biopharmaceutical company focusing on the discovery, development, manufacturing, and marketing of proprietary products for human and animal health markets. BNC has three operating divisions: Human Health, Animal Health, and Food Safety.

Financial Summary
Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2012  A -23.1 -22.5 -- 0.0 0.0 0.0 --
2011  A -14.8 -16.6 -- 0.0 0.0 0.0 --
2010  A 0.0 0.0 -- -- 0.0 -- --
Source: Aspect actuals / Thomson IBES estimates

Peer Comparison
EPS Growth (%) P/E (%) Dividend Yield (%)
Company Mkt Cap 2010 A 2011 F 2012 F 2010 A 2011 F 2012 F 2010 A 2011 F 2012 F
Acrux Limited (ACR) $604 M -0.8713 0.9752 0.7412 81.7568 41.3911 23.7721 0.0220 0.0208 0.0482
Bioniche (BNC) $1 M -- -- -- -- -- -- 0.0000 -- --
Pharmaxis (PXS) $45 M -- -- -- -- -- -- 0.0000 -- --

Market Comparison
Earnings P/E Ratio P/B Ratio P/E Growth P/S Ratio
BNC -- -- 2.06 -- 1.08
Market 0.94 12.5 0.82 1.91 2.50
Sector 1.28 15.5 2.44 0.42 6.54

Directors
Name Position Start Date
Mr Graeme McRae Executive Chairman,Chief Executive Officer 01 June 1979
Mr James Moodie Rae Non-Executive Chairman 27 July 2012
Dr James Johnson Non-Executive Director 01 September 1999
Mr Albert Beraldo Non-Executive Director 06 November 2008
Dr Stanley Alkemade Non-Executive Director 01 September 1999
Dr Margaret Cunningham Non-Executive Director 24 October 2003
Mr Lyle Vanclief Non-Executive Director 20 September 2005
Mr Rod Budd Non-Executive Director 09 November 2011

Management
Name Position
Brian Ford Chief Financial Officer
Mairi Phillips Company Secretary,Vice President
Debi Butler Corporate Controller
Andrew Grant President, Bioniche Animal Health (Global)
Rick Culbert President, Bioniche Food Safety
Cindy Benning Senior Vice-president, Operations, Quality and Regulatory Affairs
Michael Rubin Vice-president, Business Development
Monique Champagne Vice-president, Clinical Research
Jennifer Shea Vice-president, Communications, Investor & Government Relations and Assistant Corporate Secretary
Bruce McLeod Vice-president, Human Resources
Mohamed Elrafih Vice-president, Manufacturing Operations

Substantial Shareholders
Holding Name
7,550,752 (7.28%) Renaissance (London) Investments Inc

Calendar of Events
Date Event
09 October 2013 Report (Annual)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/fsg.asp.

Advertisement

Trade Shares Online from $19.95^
Free Guides

The SMH Guide to Investment Fees

An educational booklet to help you find out everything you must know about investment fees.

More details...

News

Data centres

The Age 18/06/2013 | A survey of 100 companies with more than 500 employees in Australia found 68 per cent have built a new data centre in the past two years, while 78 per cent plan to further expand or build new ones in the next 24 months.

Banks drive up index before key US Fed meeting

The Age 18/06/2013 | Renewed demand for banking stocks has driven the overall Australian sharemarket higher.

Skilled seals $75m deal

The Age 18/06/2013 | Labour hire company Skilled has increased its exposure to the oil and gas sector with a $75 million acquisition.

Pressure on ASIC over CBA fraud

The Age 18/06/2013 | A group specialising in financial disputes has called on the corporate regulator to reopen all settlements for Commonwealth Bank planners where fraud has been proven or where they failed to investigate strong allegations of fraud.

Construction Shares dumped as job cuts loom Lend Lease hit by slowdown

The Age 18/06/2013 | Investors took the knife to diversified property group Lend Lease after it warned that the global construction sector had deteriorated in the past six months, leading to reduced earnings.

Bids for satellite unit

The Age 18/06/2013 | France's Eutelsat Communications and US private equity firm KKR & Co are among the suitors to place first-round bids for Optus' satellite unit, according to overseas reports.

More...

Sponsored Links
Feedback Form